Carlsmed (NYSE: CARL) timed its IPO to coincide with favorable Medicare reimbursement codes released last October, CEO Mike Cordonnier tells Axios Pro.
Why it matters: The AI spine surgery company is the latest health care IPO this year in spite of ongoing macro headwinds.
